Professor Tom Moody (VP Technology Development and Commercialization), Dr Steve Taylor and Dr Stefan Mix (Head of Biocatalysis) highlight how Almac is approaching state-of-the-art technology development and how they guide their customers through the process of deciding how to best protect their commercial interests in relation to biocatalysis.
